BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18410968)

  • 21. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
    Oldfield EC
    Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with failure of metronidazole in Clostridium difficile-associated disease.
    Fernandez A; Anand G; Friedenberg F
    J Clin Gastroenterol; 2004; 38(5):414-8. PubMed ID: 15100520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronidazole resistance in Clostridium difficile.
    Johnson S; Sanchez JL; Gerding DN
    Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.
    Byker GL; Dinh MT; Gunaratnam NT; Robinson EA; Shehab TM; Malani AN
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):397-9. PubMed ID: 19239379
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-antibiotic associated C. difficile diarrhea in a 7 week-old infant.
    Kader A; O'Hare B; Valappil MK
    Indian Pediatr; 2004 Oct; 41(10):1045-8. PubMed ID: 15523132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile Infection in Children.
    Alvarez AM; Rathore MH
    Adv Pediatr; 2019 Aug; 66():263-280. PubMed ID: 31230698
    [No Abstract]   [Full Text] [Related]  

  • 27. Clostridium difficile-associated diarrhea in adults.
    Poutanen SM; Simor AE
    CMAJ; 2004 Jul; 171(1):51-8. PubMed ID: 15238498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients.
    Metan G; Türe Z; Kaynar L; Berk E; Gürsoy Ş; Alp E; Kılıç H; Çetin M
    J Chemother; 2015; 27(6):354-7. PubMed ID: 25407220
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
    Johnson S; Gerding DN; Louie TJ; Ruiz NM; Gorbach SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4043-5. PubMed ID: 22615287
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicrobial therapy of Clostridium difficile-associated diarrhea.
    Bouza E; Burillo A; Muñoz P
    Med Clin North Am; 2006 Nov; 90(6):1141-63. PubMed ID: 17116441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S; Nisii C; Petrosillo N
    Int J Antimicrob Agents; 2015 Jul; 46(1):8-12. PubMed ID: 25982915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis.
    Sokol H; Maury E; Seksik P; Cosnes J; Beaugerie L
    Am J Gastroenterol; 2009 Oct; 104(10):2649-50. PubMed ID: 19806111
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment.
    Simon MS
    Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043
    [No Abstract]   [Full Text] [Related]  

  • 36. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tigecycline as last resort in severe refractory Clostridium difficile infection: a case report.
    Knafl D; Winhofer Y; Lötsch F; Weisshaar S; Steininger C; Burgmann H; Thalhammer F
    J Hosp Infect; 2016 Mar; 92(3):296-8. PubMed ID: 26810610
    [No Abstract]   [Full Text] [Related]  

  • 38. Clostridium difficile infection: new insights into management.
    Khanna S; Pardi DS
    Mayo Clin Proc; 2012 Nov; 87(11):1106-17. PubMed ID: 23127735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrences in Clostridium difficile infections in cancer patients].
    García-Lozano T; Aznar-Oroval E; Martín-Utrilla S
    Med Clin (Barc); 2016 Nov; 147(9):417-418. PubMed ID: 27293195
    [No Abstract]   [Full Text] [Related]  

  • 40. An unusual case of acute abdomen -? Is it C. difficile infection.
    Limaye CS; Parikh FS; Kamath SA
    J Assoc Physicians India; 2008 Sep; 56():728. PubMed ID: 19086365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.